OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Autoimmunity is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	418
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	191
GILZ regulates type I interferon release and sequesters STAT1	158
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	152
Advances in SLE classification criteria	130
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	130
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	126
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	109
Editorial Board	105
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	100
Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis	96
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	94
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	94
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	87
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	77
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	76
Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases	73
Lupus nephritis: new progress in diagnosis and treatment	72
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia	55
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation	53
Editorial Board	51
Editorial Board	51
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus	50
Glycobiology of psoriasis: A review	49
Editorial Board	49

Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	46
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	45
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	45
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	45
Antigenic mimicry – The key to autoimmunity in immune privileged organs	43
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	39
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease	39
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	38
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	38
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations	36
Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus	35
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus	35